Skip to content
MustHave.ai Musthave.ai
AI Tools

Apple opens a U.S. study of how people use AI for health questions

Apple’s U.S. health AI study uses an iPhone app from a collaboration with OpenEvidence. Check the enrollment age, device requirements, and data choices.

Apple opens a U.S. study of how people use AI for health questions
Apple says participants can choose which HealthKit metrics to share.

The App Store’s age rating and the study’s enrollment rules give two different answers.

Apple announced the Apple Health AI Usage Study on November 15. It worked with OpenEvidence on an iPhone app where participants can ask health questions and see links to the clinical sources behind answers. Apple says it wants to study how people understand the answers, what makes them trust them, and how they act on them. Apple’s study announcement

Who can enroll

The U.S. study can enroll up to 200,000 eligible participants. Apple sets the minimum age at 21 and requires an Apple Intelligence-enabled iPhone running iOS 26 or later. The App Store rates the download 18+. Someone aged 18 through 20 can meet that rating and still fall below the study’s enrollment age. The 200,000 figure is a recruitment limit. The announcement gives no enrollment count. U.S. App Store listing

What participants can choose to share

Apple says participants decide whether to share HealthKit metrics and survey responses. It also says study data will be excluded from AI model training. The App Store disclosures list a user ID that may be linked to the person for app functionality or analytics. Read the enrollment consent for the terms that apply to conversations, optional data, and withdrawal before submitting information. Apple’s study data statement · App Store privacy disclosure

For another recent change in an Apple Intelligence workflow, see MustHave’s coverage of the Siri actions preview.

Abdessalam Alaoui

I'm Abdessalam Alaoui, founder of Musthave.AI. I write practical guides to AI models, tools, generative media.

Join the discussion

Your email address will not be published. Required fields are marked *

Keep reading

All news